Quantum-Si incorporated (QSI)
NASDAQ: QSI · Real-Time Price · USD
0.758
-0.011 (-1.38%)
At close: Nov 4, 2024, 4:00 PM
0.770
+0.012 (1.64%)
After-hours: Nov 4, 2024, 7:18 PM EST
Company Description
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS).
The company’s platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.
It is used in protein identification, protein variants, antibody characterization, biomarker identification, and post translational modification analysis applications.
The company was founded in 2013 is headquartered in Branford, Connecticut.
Quantum-Si incorporated
| Country | United States |
| Founded | 2013 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 159 |
| CEO | Jeffrey Hawkins |
Contact Details
Address: 29 Business Park Drive Branford, Connecticut 06405 United States | |
| Phone | 866 688 7374 |
| Website | quantum-si.com |
Stock Details
| Ticker Symbol | QSI |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001816431 |
| CUSIP Number | 74765K105 |
| ISIN Number | US74765K1051 |
| Employer ID | 85-1388175 |
| SIC Code | 3829 |
Key Executives
| Name | Position |
|---|---|
| Jeffrey Alan Hawkins | President, Chief Executive Officer and Director |
| Dr. Jonathan M. Rothberg Ph.D. | Founder and Executive Director |
| Jeffry R. Keyes CPA | Chief Financial Officer and Treasurer |
| Todd Rearick | Chief Technology Officer |
| Juan Esteban Avendano | Vice President of Investor Relations |
| Dr. Christian Lapointe J.D., Ph.D. | General Counsel and Corporate Secretary |
| Alex A. Hutcheson | Senior Vice President of Sales and Service |
| Katherine Atkinson | Senior Vice President of Demand Generation and Corporate Brand |
| Johan Denecke | Senior Vice President of Operations |
| John S. Vieceli | Chief Product Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 17, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Aug 27, 2024 | 8-K | Current Report |
| Aug 13, 2024 | 8-K | Current Report |
| Aug 7, 2024 | 10-Q | Quarterly Report |
| Aug 7, 2024 | 8-K | Current Report |
| Jun 28, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Jun 25, 2024 | 8-K | Current Report |
| Jun 21, 2024 | 144 | Filing |
| Jun 7, 2024 | 8-K | Current Report |
| May 30, 2024 | 8-K | Current Report |